HG
Harish Gangwani
About Harish Gangwani
Data last updated:
Harish Gangwani is a Director at Garima Healthcare Private Limited (since 1995). The companies operate in Pharma. Garima Healthcare Private Limited reported revenue of ₹37.46 Cr (FY 2025). Earlier, Harish Gangwani was an Additional Director at Eamon Drugs Private Limited (2017–2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Garima Healthcare Private Limited U85199MP1995PTC009230 | Director | 23 Mar 1995 | 1995 | ₹37.46 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Eamon Drugs Private Limited U24114MP1985PTC003021 | Additional Director | 25 Sep 2017 | 1985 | ₹15.64 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Harish Gangwani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Priya Gangwani | 05257989 | Garima Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harish Gangwani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harish Gangwani
Harish Gangwani currently holds 1 directorship: Garima Healthcare Private Limited (Director, since 23 Mar 1995, revenue ₹37.46 Cr (FY 2025)).
Harish Gangwani was first appointed on 23 Mar 1995 as Director at Garima Healthcare Private Limited. The most recent appointment on record is 25 Sep 2017 at Eamon Drugs Private Limited.
Harish Gangwani held 1 earlier board appointment: Eamon Drugs Private Limited (Additional Director, 25 Sep 2017 to 29 Jan 2018).
The current boards of Harish Gangwani's companies include Priya Gangwani (Garima Healthcare Private Limited).